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Cigarette smoking increases aortic dilatation
without affecting matrix metalloproteinase-9
and -12 expression in a modified mouse model of
aneurysm formation
Michel P. Bergoeing, MD,a Batool Arif, BS,a Amy E. Hackmann, MD,a Terri L. Ennis, BS,a
Robert W. Thompson, MD,a,b,c and John A. Curci, MD,a St. Louis, Mo
Objective: The development of abdominal aortic aneurysms (AAA) is presumed to result from multiple genetic and
environmental factors, with exposure to tobacco smoke the single largest known factor predisposing to aneurysm growth.
We have attempted to adapt the elastase-perfused animal model to determine whether tobacco exposure can lower the
threshold of aortic injury necessary for AAA development.
Methods: Adult C57BL/6 mice underwent transient perfusion of the infrarenal aorta with an active solution of elastase:
high-dose (HDE, 0.19 U/mL, n 9), standard-dose (SDE, 0.16 U/mL, n 21) or low-dose (LDE, 0.07 U/mL, n 24).
Control animals (n  24) were treated with heat inactivated elastase (HIE). Twenty LDE perfused mice were exposed to
cigarette smoke (LDE-S) beginning 2 weeks before perfusion and continuing until aortic harvest. Aortic diameter (AD) was
measured preperfusion, postperfusion, and at harvest on day 14. AAAwas defined as %AD>100%between preperfusion and
harvest. Aortas from each group (except HDE) were analyzed for matrix metalloproteinase-9 (MMP-9) and MMP-12
expression by real-time polymerase chain reaction normalized to glyceraldehyde-3-phosphate dehydrogenase.
Results: All SDEmice developed large AAA by %AD (189.3% 16.9%, mean standard error of the mean), but control
mice had only a small dilatation (69.7%  3.7%, P < .01). Higher doses of elastase did not produce larger aneurysms in
HDE mice. In contrast, only 63% of LDE mice showed aneurysmal dilatation, and these were significantly smaller
(104.3%  4.2%, P < .01). When exposed to cigarette smoke, LDE animals developed significantly larger aneurysms
(%AD, 134.5%  7.9%, P  .0021). There was no difference in normalized aortic MMP-9 and MMP-12 expression
between elastase doses or between smoke-exposed and unexposed animals. Histologic analysis revealed that smoking
increased the extent of aortic elastin degradation when compared with LDE-S animals.
Conclusion:Aneurysm development in the elastase model is dependent on the quantity of active elastase infused. Exposure
of animals to tobacco smoke after a relatively minor aortic elastase injury produces increases in elastin degradation and
aneurysm size without affecting MMP-9 or MMP-12 expression. To our knowledge, this is the first demonstration in an
animal model that smoking can act as a synergistic factor in AAA development. Further understanding of the relationship
between smoking and AAA in this model may help unveil the pathophysiologic pathways involved between cigarette
smoke and AAAs. (J Vasc Surg 2007;45:1217-27.)
Clinical Relevance: Cigarette smoking is causally associated with abdominal aortic aneurysm; however, its mechanism of
action remains unknown. The development of an animal model on which to study this relationship might lead to the
development of therapies that could inhibit aneurysm formation in these patients.From the Departments of Surgery (Section of Vascular Surgery),a Radiology,b
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8109, St. Louis, MO 63110 (e-mail: curcij@wustl.edu).Abdominal aortic aneurysms (AAAs) are thought to arise
through a combination of multiple genetic and environ-
mental factors, including advanced age, male gender, fam-
ily history, hypertension, and atherosclerosis.1-3 The stron-
gest epidemiologic risk factor known for the development
and expansion of AAAs is a history of long-term cigarette
smoking4-7: smokers have a threefold to sixfold increased
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effect of cigarette smoking on the development of AAAs is
far greater than its effect on either coronary artery or
cerebrovascular disease.7,8 Based on these and other data,
the United States Surgeon General in 2004 made the
determination that cigarette smoking is causally related to
aortic aneurysm disease.9 Although little is yet known
about the specific mechanisms linking cigarette smoking
and AAAs, a better understanding of this relationship will
yield valuable insights into the complex pathogenesis and
pathophysiology of aneurysm disease.7,10-13
Much of our current understanding of the pathophys-
iology of AAAs has come from studies using animal models
of disease, such as the aneurysmal aortic lesions that typi-
cally develop after transient perfusion of the abdominal
aorta with porcine pancreatic elastase (PPE).14 This exper-
imental model has been well-characterized in rats andmice,
where it has been used to clarify molecular mechanisms of
the role of inflammatory mediators and elastin-degrading
matrix metalloproteinases (MMPs) in AAAs, as well as the
potential for pharmacologic treatment to suppress aneu-
rysm formation.
Another advantage of the murine experimental model
is its potential to be concurrently exposed to cigarette
smoke in the same manner that has been used to model the
development of tobacco-associated pulmonary diseases,
such as lung cancer and emphysema. This approach may be
particularly fruitful in examining potential similarities be-
tween the mechanisms underlying destructive remodeling
of elastin-rich extracellular matrix in experimental pulmo-
nary emphysema and AAAs, which are both characterized
by chronic inflammation and increased tissue expression of
elastolytic MMPs.14,15
In a recent preliminary study, we demonstrated that
mice exposed to cigarette smoke exhibited a relative in-
crease in the size of elastase-induced experimental AAAs
during a period of 3 months, but that smoke exposure had
no significant effects on aneurysm development or size
during the initial 2 weeks after elastase perfusion.16 This
was an important limitation to investigating the role of
cigarette smoking in AAAs, in that the processes of aortic
wall inflammation, proteinase expression, degradation of
medial elastin, and aneurysm formation are typically most
pronounced or completed 14 days after elastase perfu-
sion.
To address this concern, the goal of the present inves-
tigation was to create a more pathophysiologically relevant
model of aneurysmal degeneration in which the effects of
cigarette smoke exposure could be examined during the
initial phase of aortic inflammation and degeneration of the
elastic media. We initially evaluated whether modifying the
elastase perfusion procedure with a reduced concentration
of elastase might result in submaximal aortic injury and
partial aneurysm formation. We then tested the hypothesis
that cigarette smoke exposure in animals undergoing sub-
maximal elastase-induced injury would result in pathologic
changes comparable to those induced by standard elastase-
induced injury in nonsmoking animals. We also predictedthat the effects of cigarette smoking during aneurysm de-
velopment might be mediated by increased local expression
of elastolytic matrix-degrading proteases, such as MMP-9
and MMP-12, and sought to specifically examine this pos-
sibility.
METHODS
Elastase perfusion model of AAA. Adult male
C57BL/6J (Jackson Laboratory, Bar Harbor, Me) mice
underwent transient perfusion of the abdominal aorta
according to a protocol approved by the Animal Studies
Committee at Washington University School of Medi-
cine as described in the Expanded Methods in the Ap-
pendix (online only) and in previous reports.16 Three
different concentrations of type I PPE (E-1250, Sigma,
St. Louis, Mo) were used, designated as high-dose elas-
tase (HDE, 0.19 U/mL), standard-dose elastase (SDE,
0.16 U/mL), and low-dose elastase (LDE, 0.07
U/mL). An additional group of mice underwent aortic
perfusion with heat-inactivated elastase (HIE) as a neg-
ative control, in which the standard dose elastase solu-
tion was heated to 100°C for 30 minutes to eliminate
enzymatic activity.
Because commercial PPE preparations exhibit signifi-
cant batch-to-batch variability inmeasured protease activity
as well the capacity to induce AAAs,17,18 the standard dose
of elastase that is required to reproducibly induce AAAs in
this experimental model is determined empirically for each
commercial lot of PPE. After preliminary experiments for
this study determined that there was satisfactory induction
of AAAs at an elastase concentration of 0.16 U/mL, which
was thereafter designated as the standard concentration, all
of the experiments conducted here were performed with a
single PPE preparation derived from the same commercial
source and lot.
Preperfusion aortic diameter (AD) was measured be-
fore isolation of the abdominal aorta at the time of elastase
perfusion, and postperfusion AD was measured at least 5
minutes after successful restoration of arterial flow. Final
AD measurements were obtained in vivo immediately be-
fore euthanasia. For each animal, the extent of aortic dila-
tion was calculated as the percentage increase between the
preperfusion and postperfusion AD (immediate AD), the
percentage increase between postperfusion and final AD
(interval AD), and the percentage increase between final
and preperfusion AD measurements (overall AD). Most
mice were euthanized 2 weeks after elastase perfusion,
except 11 LDE perfusedmice that were euthanized 3 weeks
after perfusion.
Cigarette exposure of mice. Mice were subjected to
cigarette smoke according to a protocol designed to induce
the development of experimental pulmonary emphysema,
as previously described.19 Specially designed cages were
used to expose the animals to smoke from three University
of Kentucky 2R4F research cigarettes (filter removed) for 1
hour daily, 6 days per week. This level of smoke exposure is
effectively equivalent to that produced with two University
of Kentucky 2R1 cigarettes (which are no longer pro-
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used for the prolonged period of 3 to 6 months required to
induce development of pulmonary emphysema.19
Mice underwent the cigarette smoke exposure protocol
for 2 weeks before the elastase perfusion procedure, and the
cigarette smoke exposure continued on the same schedule
until the time of euthanasia at 2 weeks. Littermate mice
were maintained with identical diets during the same pe-
riod of time and served as controls.
During the course of these experiments we observed no
differences in periprocedural technical complications, tol-
erance for anesthesia, or immediate death between the
smoking and nonsmoking mice that had undergone the
elastase perfusion procedure.
Light microscopy. After euthanasia, a subset of mice
underwent systemic perfusion and fixation with 10% neu-
tral buffered formalin. The abdominal aorta was excised
and immersed in 10% neutral buffered formalin for 24
hours and then embedded in paraffin. Aortic 5-m cross
sections were mounted and stained with hematoxylin and
eosin for regular histology or Verhoeff van Gieson stain for
elastin. Representative sections were obtained from animals
in each treatment group and were imaged. Six individuals
unaware of the experimental group scored these photomi-
crographs, as previously described.20 The elastin content
(absent elastin to normal elastin) and the degree of inflam-
matory infiltration (absent inflammation to severe inflam-
mation) were evaluated on a scale from 0 to 4, and the
mean  standard error score was calculated.
RNA extraction for real-time polymerase chain re-
action and gene expression analysis. Fresh aortic speci-
mens immediately after harvest were disrupted and homog-
enized in 400 L of Trizol reagent (Invitrogen Corp,
Carlsbad, Calif), and then chloroform (20% vol) was added
and the sample was spun in a microcentrifuge at 12,000g
for 15 minutes. The resultant supernatant was collected
and an equal volume of ethanol (70% vol) added. The
mixture was then loaded into an RNEasy Micro Kit spin
column (Qiagen Inc, Valencia, Calif), and total RNA was
collected in 14 L of RNase-free water.
Synthesis of complementary DNA (cDNA) was per-
formed on a GeneAmp PCR System 9700 (Applied Biosys-
tems, Foster City, Calif) with 100 L of standard reaction
mixture as provided in the GeneAmp RNA PCR kit (Ap-
plied Biosystems). The reaction products served as a tem-
plate for real-time polymerase chain reaction (RT-PCR)
amplification on a 7500 Fast Real-Time PCR System (Ap-
plied Biosystems) in 25 L total reaction volume with
Power Syber Green Master Mix (Applied Biosystems), 10
pmol each forward primer and reverse complement primer,
and 0.2 g of cDNA. The reaction was incubated at 95°C
for 10 minutes for DNA polymerase (AmpliTaq Gold,
Applied Biosystems) activation, then 40 cycles of denature
for 15 seconds at 95°C and annealing/extend at 60°C for 1
minute. Results of MMP-9 and MMP-12 were normalized
and expressed as pg/pg glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH).Noninvasive blood pressure measurements. Non-
invasive determinations of systolic and diastolic blood pres-
sure were made in conscious mice using a tail-cuff system
(RTBP2005; Kent Scientific, Litchfield, Conn). Pressures
in smoke-exposed and non-exposed mice were measured at
least 7 days after perfusion and preceding harvest during 4
consecutive days. Blood pressure results represent themean
of the last three sessions for each mouse on consecutive
days. Mean arterial pressure was calculated as described
elsewhere.21
Urine cotinine measurements. Urine was collected
from a subset of mice exposed to tobacco smoke by squeez-
ing the bladder while the mouse was anesthetized at the
time of aortic perfusion. Urine was again collected at the
time of euthanasia by bladder puncture and aspiration.
Urine cotinine concentration was evaluated using a modi-
fication of a cotinine enzyme-linked immunosorbent assay
(ELISA) originally developed to assay cotinine in saliva
(Salimetrics, State College, Pa). The standard protocol was
followed, with the exception that the samples and the
standards were diluted in a synthetic urine matrix, Surine
(Dyna-Tek, Lenexa, Kan). Samples were assayed in dupli-
cate.
Statistical analysis. The results are expressed as mean
 standard error of the mean. Logarithmic transformation
of the MMP expression data was necessary to create a
normal data distribution for statistical analysis. Statistics
used for multiple sample experiments included one-way
analysis of variance (ANOVA) or Welch ANOVA for un-
equal variances when appropriate and Tukey-Kramer mul-
tiple comparison post-test. Two-sample analysis was per-
formed using the unpaired t test, assuming unequal
variances. Presence of an aneurysm at harvest was defined as
an increase of 100% over the preperfusion aortic diame-
ter. The 2 (or the Fisher exact test when average cell size
was5) was used to test for differences in incidence of AAA
between groups. All analyses were performed with JMP 5.1
statistical software (SAS Institute Inc, Cary, NC) for Win-
dows (Microsoft, Redmond, Wash), and P  .05 was
considered significant.
RESULTS
Effect of varied elastase concentrations on standard
model of aneurysm development. To determine the ef-
fect of different concentrations of PPE on experimental
aneurysm development, three experimental groups were
treated with successful perfusions of standard-dose (SDE, n
 12), high-dose (HDE, n  9), and low-dose elastase
(LDE, n 24) concentrations, and a fourth control group
was treated with heat-inactivated elastase (HIE, n  24).
Aortas from all groups were harvested at 2 weeks postper-
fusion.
No significant difference was found in preperfusion AD
among the groups, and immediately postperfusion there
were also no significant differences in the immediate %AD
among the groups, with the exception of the comparison
between the HDE and HIE mice (HDE, 72.5%  2.7%;
SDE, 64.3%  3.2%; LDE, 62.2%  1.9%; HIE, 56.8% 
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to prior reports comparing SDE and HIE perfusion, no
significant difference was found in the immediate postper-
fusion elastin content between aortas in LDE and HIE
groups.
As expected, a minimal increase occurred in the interval
%AD (8.4% 2.2%) in the animals treated with the HIE,
but continued dilatation (75.9%  9.5%) was noted in
animals treated with SDE, with all mice developing aneu-
rysms by 2 weeks (Fig 1, B and C). Histologically, the
aortas of mice treated with HIE had intact elastic lamina
and minimal inflammatory infiltrate, whereas the SDEmice
had minimal or absent elastic lamellae and extensive inflam-
matory infiltrates.
Although the immediate postperfusion diameter of the
HDE-perfused mice was significantly larger than that seen
in HIE-perfused mice, no additive effect was seen on the
interval or overall %AD compared with the SDE-treated
mice (179.8% 12.8% vs 189.3% 16.9%; PNS). There
was also no difference in the histologic changes at harvest
with HDE perfusion compared with SDE.
Reducing the concentration of elastase infused signifi-
cantly altered the development of aortic dilatation at 2
Fig 1. A-C, Effect of varying doses of elastase on aor
transient aortic perfusion with a solution of high-dose (H
Heat-inactivated elastase (HIE) was used as a control. A
C, overall aortic dilatation. Comparisons were calculate
comparisons test.D-F, Effect of varying incubation time
mice were subjected to transient aortic perfusion with a
14-day time-point or 21 days after perfusion (LDE D21)
and F, and overall aortic dilatation. Comparisons were ca
Not significant.weeks, essentially creating intermediate changes betweenHIE and SDE perfusion. Perfusion of the murine aorta
with LDE resulted in an overall %AD that was significantly
smaller than SDE-perfused mice (104.3%  4.2% vs
189.3% 16.9%, P .05), but was significantly larger than
the HIE-perfused mice (69.7%  3.7%, P  .05). Aneu-
rysms developed in all SDE or HDE mice, whereas aneu-
rysms were present in only 63% of the LDE mice and 4% of
the HIE mice (P  .017 LDE vs SDE; P  .0001 LDE vs
HIE).
The histology of the aortas from the LDE mice dem-
onstrated significant elastin loss and increased inflamma-
tory infiltration compared with HIE mice. Yet when com-
pared with SDE-perfused aortas, the preservation of the
elastic lamellae was significantly better, whereas the degree
of inflammatory cell infiltration was similar (Fig 4, C).
Effect of extended aneurysm incubation in mice
perfused with low-dose elastase. To determine whether
the smaller mean interval and overall %AD seen in the
LDE mice simply reflected a prolonged time course for
aneurysm development when a lower dose of elastase was
used, we increased incubation time (perfusion to harvest)
to a total of 3 weeks in a subgroup of 11 LDE mice. We
found that samples from animals harvested 3 weeks after
eurysm (AAA) dilatation. C57BL/6 mice underwent
standard-dose (SDE) or low-dose active elastase (LDE).
ediate aortic dilatation, B, interval aortic dilatation, and
h one-way analysis of variance and the Tukey multiple
tperfusion to harvest) in LDE-perfused mice. C57BL/6
tion of LDE. Mice were then harvested at the standard
Immediate aortic dilatation, E, interval aortic dilatation,
ed with unpaired t test assuming unequal variances.NS,tic an
DE),
, Imm
d wit
(pos
solu
.D,
lculatLDE perfusion were not different than those harvested at 2
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26.2%  2.7%, P  NS; Fig 1, E) and overall %AD
(113.8%  8.4% vs 104.2%  4.2%, P  NS; Fig 1, F). The
incidence of aneurysms was also similar in each group (63%
vs 73%; P  NS).
Effect of tobacco smoke exposure on model aneu-
rysm development. To evaluate the effect of cigarette
smoke on model aneurysms, mice were exposed to ciga-
rette smoke for 2 weeks before elastase perfusion, and
exposure was continued until harvest. Littermate mice
were maintained with identical diets during the same
period of time and served as controls. LDE was perfused
in 23 smoke-exposed mice (LDE-S) and SDE was per-
fused in 14 smoke-exposed mice (SDE-S), and their
aortas were harvested after an additional 2-week incuba-
tion.
Animals exposed to preoperative tobacco smoke did
not demonstrate a different initial response to elastase
perfusion. The immediate %AD (Fig 2, A and D) induced
by aortic perfusion was not different between smoke-
exposed and unexposed animals (SDE, 66.8%  2.6% vs
64.3%  11.1%, P  NS; LDE, 64.2%  3.2% vs 62.2% 
Fig 2. Effect of smoking on abdominal aortic aneurysm
perfusion with a solution of standard-dose (SDE) or low-
(n 20) were exposed to cigarette smoke for 2 weeks be
A-C, Effect of smoking on SDE-perfused mice. A, Imm
overall aortic dilatation. Comparisons were calculated wi
smoking on LDE-perfused mice. D, Immediate aortic
dilatation. Statistical comparisons were calculated on the
unequal variances. NS, Not significant.1.9%, P  NS). There were also no grossly apparentchanges in the technical aspects of the model or survivabil-
ity of the animals.
In the SDE animals, at harvest there was no significant
effect on either interval %AD (53.6%  7.4% vs 75.9% 
9.5%, PNS) or overall %AD (156.3% 13% vs 189.3%
 16.9%, P  NS) when comparing SDE-S and control
animals (Fig 2, A to C). There was also no impact on the
incidence of AAA (93% vs 100%, PNS). Cigarette smoke
exposure in the LDE mice, however, resulted in a nearly a
60% increase in the aortic mean interval %AD (41.5% 
4.0% vs 26.2% 2.7%, P .004) compared with nonsmok-
ing animals (Fig 2, E). On the whole, there was a 30%
increase in the overall %AD in LDE-S mice compared
with control animals (134.5% 7.9% vs 104.2% 4.2%, P
 .003).
There were also more aneurysms among the mice ex-
posed to smoke, although the difference did not quite reach
the threshold for statistical significance (85% vs 63%, P 
.08). Concordant with the changes seen in absolute aortic
diameter were increases in elastic fiber loss in the LDE-S
animals compared with the LDE animals. Furthermore,
) dilatation. C57BL/6mice underwent transient aortic
active elastase (LDE). SDEmice (n 14) and LDEmice
urgery and then continued smoking until aortic harvest.
te aortic dilatation, B, interval aortic dilatation, and C,
paired t test assuming unequal variances. D-F, Effect of
tion, E, interval aortic dilatation, and F, overall aortic
change in aortic size with the unpaired t-test assuming(AAA
dose
fore s
edia
th un
dilata
meananimals exposed to tobacco smoke for 4 weeks before LDE
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with animals exposed for only 2 weeks (data not shown.)
Effect of tobacco smoke exposure on blood
pressure. To determine whether smoke-induced hyper-
tension might be related to the increased aneurysm size in
the LDE-S animals, we evaluated the blood pressure in
smoke-exposed (n  24) and control (n  16) mice after
aortic perfusion. Noninvasive tail-cuff measurements of
systolic and diastolic blood pressure were performed in
mice after aortic perfusion. In these mice, cigarette smok-
ing had no effect on systolic or diastolic blood pressure, or
mean arterial pressure (Table).
Urinary cotinine in smoke-exposed animals. To as-
sess the consistency of smoke exposure in the animals, urine
was obtained from animals both at the time of aortic
perfusion and at euthanasia. Quantification of urinary coti-
nine concentration was performed using a commercially
available ELISA. All smoke-exposed animals had similarly
elevated levels of urinary cotinine at harvest. Mean urinary
concentration of cotinine did not vary when measured at
the time of surgery or at harvest.
Matrix metalloproteinase-9 and -12 expression in
murine aortas. To determine whether changes in produc-
tion of elastolytic proteases MMP-9 or MMP-12 may play
a role in the differences in aortic aneurysm formation seen
between elastase doses and with smoke exposure, aortas
from each group (SDE, n  8; SDE-S, n  12; LDE, n 
12; LDE-S, n  17, and HIE, n  15) were analyzed for
MMP-9 and MMP-12 expression. Results of MMP-9 and
MMP-12 analysis are expressed after normalization to
GAPDH.
Despite the large differences in aortic diameters based
on the quantity of elastase perfused, aortic MMP-9 expres-
sion levels at 14 days were not significantly affected by
elastase dose or activity (SDE, 1.3  102  3.3  103;
LDE, 2.1  102  6.9  103; HIE, 1.2  102  2.8
 103; P  NS; Fig 3, A). Likewise, aortic MMP-12
messenger RNA (mRNA) levels were also similar irrespec-
tive of the perfusion dose of elastase (SDE, 4.3  101 
1.6 101; LDE, 4.1 101 1.1 101; HIE, 1.2
101  2.5  102; ANOVA P  NS; Fig 3, B).
We also compared the production of MMP-9 and
MMP-12 based on tobacco smoke exposure in the SDE
and LDE mice. In this analysis, smoking had no influence
Table. Noninvasive arterial blood pressure measurements*
Treatment†
Mice
(n)
Systolic
(mmHg)
Diastolic
(mmHg)
Mean
(mmHg)
No smoke 24 89.4  2.9 76.2  2.8 80.6  2.8
Smoke 16 90.9  3.6 76.5  3.2 81.3  3.3
*Noninvasive systolic and diastolic arterial blood pressure was measured in
conscious smoke-exposed and control mice, at least 7 days after perfusion
and before harvest at day 14. Mean arterial pressure was calculated as
described elsewhere.
†Two-way comparisons were calculated with unpaired t test assuming un-
equal variances, and results were not significant.on aortic MMP-9 mRNA levels (SDE-S, 1.9 102 4.8 103 vs 1.3 102 3.3 103, PNS; LDE-S, 8.5
 103  1.4  103 vs 2.1  102  6.9  103, P 
NS; Fig 3, C). We were also unable to demonstrate any
significant difference in normalized MMP-12 levels when
comparing the smoke-exposed and unexposed mice.
(SDE-S, 3.7 101 6.3 102 vs 4.3 101 1.6
101, PNS; LDE-S, 2.5 101 4.8 102 vs 4.1
101  1.1  101, P  NS; Fig 3, D).
DISCUSSION
AAA is a distinct pathologic condition that is believed
to require a convergence of multiple predisposing factors.
Both genetic and environmental elements have been iden-
tified in the pathogenesis of this disease, of which tobacco
smoke exposure is the largest epidemiologic factor predis-
posing to aneurysm development and growth.5-7,11,22 His-
tologically, the disease is characterized by the development
of aortic wall inflammation and accompanied by significant
medial elastic fiber degeneration attributed to increased
local production of several elastolytic metallopro-
teases.23-27 These histologic changes have been recapitu-
lated in several animal models including the murine
elastase-perfusion model.
These models have been useful in advancing our under-
standing the pathophysiology of AAA, yet they offer little
insight into the processes that may initiate aneurysm for-
mation in humans. Modeling the arterial changes induced
by tobacco smoke may offer our first means by which to
study the events that lead to aneurysm formation. The
success of tobacco smoke exposure in animals to model
pulmonary disease suggests that such exposure in mice may
have similar pathologic effects to the changes induced by
smoke exposure in humans. It is remarkable to note that the
matrix changes of a model of emphysema includes chronic
inflammatory infiltration with upregulation of expression of
MMP-2, MMP-9, and MMP-12.28-34
The only previously published study on cigarette smoke
and model aneurysms was not able to show any effect of
tobacco smoke on initial aneurysm development.16 How-
ever, mild progressive dilatation was noted after a pro-
longed postperfusion interval with tobacco smoke. Al-
though this conforms to the human epidemiologic finding
that AAA expansion is accelerated with ongoing smoke
exposure,35,36 their model did not mimic the extensively
documented effects of tobacco smoke on the risk of aneu-
rysm development.5,37-40
Further, there were multiple other limitations of that
model to determining the effect of tobacco smoke on
AAA development. Unlike nearly all other published
studies on the elastase-perfused murine AAA that have
used the C57/Bl6 strain, the mice used were of the
129/SvEv strain, a strain recognized to be more resistant
to aneurysm development than the C57 strain.41 Based
on the timing of the changes, it is most likely that the
difference seen was related to an effect of tobacco smoke
on the repair and stabilization of the injured aorta. This
may be more related to the unique features of the model
AAA rather than representative of the changes seen in
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bacco smoke do not continue to dilate after 2 weeks,
whereas clinical AAA nearly invariably demonstrate pro-
gressive dilatation.42 Finally, that study did not describe
the histologic or any biochemical changes that accompa-
nied the increase in diameter, making it unclear what
effect tobacco smoke exposure was having on the aortic
wall.
These preliminary results were promising, but the
utility was limited, and we desired to model the effects of
tobacco smoke on the critical initiating events of aneu-
rysm formation. We hypothesized that the standard
model of elastase-induced aneurysm formation creates a
Fig 3. A and B, Effect of varying doses elastase on m
underwent transient aortic perfusion with a solution o
Heat-inactivated elastase (HIE) was used as control. At
RNA (mRNA) extraction. A,MMP-9 expression. B,MM
analysis and differences were calculated with one-way ana
test.C andD, Effect of smoking onMMP expression. C5
a solution of SDE or LDE. SDE mice ( n 14) and LD
before surgery and then continued smoking until aortic
mRNA extraction. C, MMP-9 expression in SDE and
Results were normalized to log base 10 for analysis, an
unequal variances. NS, Not significant.maximal aortic injury response pattern, effectively mask-ing any effect of additional inflammatory or matrix de-
grading stimuli, including that potentially borne with
tobacco smoke. This was confirmed by the lack of addi-
tional dilatation at harvest in mice perfused with the
highest concentration of elastase.
The perfusion model was then modified with a lower
concentration of elastase in the perfusate. The result in
these animals with LDE perfusion was an aneurysm inter-
mediate both by diameter measurement and histology be-
tween control and SDE perfusion. When these LDE-
perfused mice were euthanized at 3 weeks postperfusion
rather than at the standard 2 weeks, no further increase in
AAA size was noted, suggesting that LDE perfusion creates
metalloproteinase (MMP) expression. C57BL/6 mice
ndard-dose (SDE) or low-dose active elastase (LDE).
est aortic tissue was promptly processed for messenger
2 expression. Results were normalized to log base 10 for
of variance and Tukey-Kramer multiple comparison post
/6mice were subjected to transient aortic perfusion with
e (n 20) were exposed to cigarette smoke for 2 weeks
est. At harvest aortic tissue was promptly processed for
mice. D, MMP-12 expression in SDE and LDE mice.
ferences were calculated with unpaired t test assumingatrix
f sta
harv
P-1
lysis
7BL
E mic
harv
LDE
d difa submaximal aortic dilatation and matrix injury compared
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dilation.
To determine whether smoke exposure would signifi-
cantly alter the development of model AAA in these sub-
maximally injured aortas, we exposed mice to cigarette
smoke for 2 weeks before aortic perfusion with LDE. The
mice were then continuously exposed to cigarette smoke
during the next 2 weeks before harvest. This smoke expo-
sure in the LDE-perfused mice resulted in significantly
larger aneurysms when compared with the LDE-perfused
mice that were not exposed to smoke.
On histology, the aneurysms in the LDE-S mice dem-
onstrated elastin degradation similar to that seen in the
SDE-perfused mice (Fig 4). Given the lack of increase in
aortic diameter at 3 weeks in the LDE-perfused mice, this
effect of smoking does not appear to be an acceleration of
an ongoing injury induced by the LDE perfusion. We also
demonstrated that there was no effect on mean blood
pressure, a potential mediator of increased aortic dilatation,
in the LDE-S mice after the relatively short exposures to
cigarette smoke used in this study.
Of interest was that we did not see a dose-response
relationship between pre-elastase smoke exposure and an-
eurysm size. This suggests that the effect of smoke exposure
in this model may be a permissive one, such that smoke
exposure enhances the matrix-degrading process activated
by a second phenomenon (ie, low-dose elastase injury).
This may be consistent with human epidemiology where
the quantity of tobacco exposure is only roughly correlated
with the incidence of aneurysms, although more rapid
growth of aneurysms occurs in those who continue to
smoke.35,36
In the mice not exposed to smoke, we found no rela-
tionship between elastase dose or aneurysm size and
MMP-9 or MMP-12 production in the aortic wall. This
confirms the results of a recent study that used microarrays
to compare aortic expression ofMMPs at harvest in animals
perfused with SDE and HIE.43 Nevertheless, prior studies
in genetically modified animals demonstrate thatMMP-9 is
critical to aneurysm formation in the murine model of
AAA.14 Further studies will be necessary to clarify the
relationship between the expression of these proteases and
their activity within the aortic wall.
Fig 4. Murine aortic wall histology.A–F, Staining of ao
emphasize the elastic fibers in the tissue. Aortas shown i
and panelsD and E were perfused with standard-dose el
heat inactivation. Panel G plots the mean  standard er
(LDE) perfused aortas. Both elastin and inflammation
representing greater amounts of elastin or inflammation,
perfusion and demonstrate intact elastin fibers and n
inflammatory infiltration and severe elastin damage is
damage is seen 2 weeks after LDE perfusion, despite a sign
more inflammation and elastin degradation in LDE-pe
photomicrographs are high-power views (original magn
magnification 20). *P  .001 compared with day 0; #P  .We also did not find a significant difference in the local
production of either MMP-9 or MMP-12 in the mice
exposed to smoke compared with the control mice. Given
the local upregulation of MMP-12 expression in the lungs
of mice exposed to cigarette smoke, we anticipated that
effect might carryover in the macrophages recruited to the
aorta during the formation of the aneurysm. Our findings
here suggest a more indirect relationship between matrix
changes in the lungs and the aorta in mice exposed to
cigarette smoke. To fully evaluate the impact of protease
changes on the development of aneurysms in smoke-
exposed mice, analysis of the protease activity of the aortic
tissues will also be required. Future studies examining the
time-course ofMMP expression will also need to be done in
the smoke-exposed mice as well as in genetically altered
mice.
Alternatively, the effect of tobacco smoke on AAA
development may lie in factors not directly related toMMP
production, such as other inflammatory mediators or in
changes in the arterial inflammation response profile. For
example, Paik et al44 showed that nitrite ion, a byproduct of
cigarette smoke, is capable of binding under physiologic
conditions to insoluble elastin. They also showed that
segments of human aortic wall treated with nitrite ion
resulted in structural disruption of elastin.
CONCLUSIONS
To our knowledge, this is the first demonstration in an
animal model that smoking can act as a synergistic factor in
AAA formation, confirming the effect of cigarette smoke
exposure on the human disease and opening exciting new
possibilities in aneurysm research. This study is the first step
in understanding the in vivo effects of tobacco smoke
exposure on the arterial wall. Of importance is that it may
also allow us to begin to understand the changes that may
initiate AAA development. Future studies are needed to
further delineate the changes in the arterial wall and the
inflammatory response induced by cigarette smoke expo-
sure. We anticipate extensive use of this model to further
our understanding of the pathophysiology of aneurysm
disease.
ctions was performed with Verhoeff-van Gieson stain to
els A, B, and C were all perfused with low dose elastase
(SDE). Panel F was perfused with SDE that underwent
f the blinded grading of sections from low-dose elastase
graded on a scale from 0 to 4, with higher numbers
ctively. Samples in A andD were fixed immediately after
reciable cellular infiltrate. D, After 2 weeks, marked
in SDE-perfused animals. B, Relatively modest elastin
t inflammatory infiltrate.C andG,There is significantly
animals that are also exposed to cigarette smoke. All
ion 100), and insets are at low-power view (originalrtic se
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astase
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ificat001 compared with control.
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Extended Methods
Elastase perfusion model and aortic diameter
measurements. Adult male C57BL/6J mice underwent
transient perfusion of the abdominal aorta according to a
protocol approved by the Animal Studies Committee at
Washington University School of Medicine. Mice were
anesthetized with intraperitoneal sodium pentobarbital (55
to 60 mg/kg) and a laparotomy was performed under
sterile conditions. The abdominal aorta was exposed with
the assistance of an operating stereomicroscope (Leica Mi-
crosystems, Wetzlar, Germany) from the level of the left
crossing renal vein to the bifurcation, and the lumbar
branches were ligated with 9-0 sutures.
Preperfusion aortic diameter (AD) was measured with a
calibrated ocular grid, and temporary 6-0 silk ligatures were
placed around the proximal and distal aorta. An aortotomy
was created at the level of the bifurcation using the tip of a
30-gauge needle. A heat-tapered segment of PE-10 poly-
ethylene tubing (Baxter, McGraw Park, Ill) was introduced
through the aortotomy and secured in place with a 6-0 silk
tie, and the aorta was perfused for 5 minutes with a saline
solution containing active or inactive type I porcine pan-
creatic elastase (PPE; 7.8 U/mg; catalog E-1250, Sigma
Chemical Co, St. Louis, Mo). The concentrations of PPE
were varied as follows: high-dose elastase (HDE, 0.19
U/mL), standard-dose elastase (SDE, 0.16 U/mL), low-
dose elastase (LDE, 0.07 U/mL), and heat-inactivated
elastase (HIE, 0.16 U/mL, 100°C for 30 minutes). After
perfusion, the catheter was removed, and the aortotomy
was closed with a 10-0 suture.
Postperfusion ADwas measured at least 5 minutes after
successful restoration of arterial flow. Final AD measure-
ments were obtained in vivo during a repeat laparotomy
before the animal was killed and tissue procured.
For each animal, the extent of aortic dilation was cal-
culated as the percentage increase between the preperfu-
sion and postperfusion AD (immediate %AD), the per-
centage increase between postperfusion and final AD
(interval %AD), and the percentage increase between final
and preperfusion AD measurements (overall %AD). Ab-
dominal aortic aneurysm (AAA) was defined as an overall
%AD of at least 100%. All mice were euthanized 2 weeks
after elastase perfusion, except 11 LDE-perfused mice,
whose aortas were harvested 3 weeks after the initial proce-
dure (LDE D21).
During and immediately after aortic perfusion, overall
perioperative mortality (surgery to 48 hours including an-
imals euthanized because of anatomic variations or techni-
cal complications) was 30.3% and did not significantly vary
based on the perfusate elastase concentration (2 analysis).
Similarly, the perioperativemortality in themice exposed to
cigarette smoke before the procedure was 27.3%, which
also did not vary based on perfusate (2 analysis). Mortality
among the mice was rare in both treatment groups beyond48 hours after elastase perfusion (no smoke, 9.2%; smoke,
7.5%; 2 P  NS).
Mouse model of cigarette smoking. Mice were ex-
posed to cigarette smoke according to a previously de-
scribed protocol to induce the development of experimen-
tal pulmonary emphysema.17 Using specially designed
cages and a smoking apparatus adapted for mice, animals
were exposed to smoke from 3 University of Kentucky
2R4F research cigarettes (filter removed) daily for 6 days
per week. It has been observed that for periods of up to 6
months, blood carbon monoxide does not reach toxic
levels, and mice appear grossly normal throughout the
entire experimental procedure.17
Light microscopy. After death, mice underwent sys-
temic perfusion and fixation with 10% neutral buffered
formalin. The abdominal aorta was excised and immersed
in 10% neutral buffer formalin for 24 hours and then
embedded in paraffin. Aortic cross sections (5 m thick)
were then mounted and stained with hematoxylin and
eosin for regular histology or Verhoeff van Gieson stain for
elastin. Representative cross-sectional areas from each spec-
imen were photographed. Aortas from normal nonperfused
SDE day 0 and LDE day 0 (without smoke exposure) mice
were used as controls.
RNA extraction for real-time polymerase chain
reaction and gene expression analysis. Fresh aortic spec-
imens immediately after harvest were disrupted and ho-
mogenized in 400 L of Trizol reagent (Invitrogen Corp,
Carlsbad, Calif) and then chloroform (20% vol) was added
and the sample was spun in a microcentrifuge at 12,000g
for 15 minutes. The resultant supernatant was collected,
and an equal volume of ethanol (70% vol) was added.
Themixture was then loaded into an RNEasyMicro Kit
spin column (Qiagen Inc, Valencia, Calif), and total RNA
was collected in 14 L of RNase-free water. Synthesis of
complimentary DNA (cDNA) was performed on a
GeneAmp PCR System 9700 (Applied Biosystems, Foster
City, Calif) with 100 L reaction volume using 2 g of
total RNA, 1 U/L RNase inhibitor, 1 U/L recombi-
nant Moloney murine leukemia virus reverse transcriptase,
2.5 M random hexamers, 1 mM 2’-deoxyribonucleoside
5’-triphosphate, 5 mM magnesium chloride solution, and
1 polymerase chain reaction (PCR) buffer as provided in
the GeneAmp RNA PCR kit (Applied Biosystems). Reac-
tions were incubated at 25°C for 10 minutes. Reverse
transcription was initiated by heating to 48°C for 30 min-
utes and terminated by heating to 95°C for 10 minutes.
The reaction products served as a template for real-time
PCR amplification using the following mouse MMP and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for-
ward primers (FP) and reverse complement primers (RCP), all
from Integrated DNA Technology Inc; Coraville, Iowa:
MMP-9: FP 5=-ACAATCCTTGCAATGTGGAT-
GTT-3=, RCP 5=-CGCCCTGGATCTCAGGAATA-3=;
MMP-12: FP 5=-TTAACCCCAGCACATTTCGC-3=,
RCP 5=-ACTGAATGTTACGTATGTCATCAGCA-3=;
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RCP 5=-TCTTCTGGGTGGCAGTGATG-3=.
The reactions were performed on a 7500 Fast Real-
Time PCR System (Applied Biosystems) in 25 L of total
reaction volume with Power Syber Green Master Mix (Ap-
plied Biosystems), 10 pmol each FP and RCP, and 0.2 g
of cDNA. The reaction was incubated at 95°C for 10
minutes for DNA polymerase (AmpliTaq Gold, Applied
Biosystems) activation, then 40 cycles of denature for 15
seconds at 95°C and annealing/extend at 60°C for 1
minute. The resultant product was normalized with
GAPDH, and absolute quantitation was calculated using a
standard curve.
Noninvasive blood pressure measurements. Non-
invasive determinations of systolic and diastolic blood pres-
sure were made in conscious mice using a tail-cuff system
(RTBP2005; Kent Scientific, Litchfield, Conn). Pressures
in smoke-exposed and control animals were measured at
least 7 days after perfusion and preceding harvest at day 14
during 4 consecutive days. To optimize the pulse signal,ments were recorded for each mouse per session. Blood
pressure results represent the mean of the last three sessions
for each mouse on consecutive days. Mean arterial pressure
was calculated as described elsewhere.18
Statistical analysis. The results are expressed as
mean  standard error of the mean. Logarithmic trans-
formation of the MMP expression data was necessary to
create a normal data distribution for statistical analysis.
Statistics used for multiple sample experiments include
one-way analysis of variance (ANOVA) or Welch
ANOVA for unequal variances, when appropriate, and
Tukey-Kramer multiple comparison post-test. Two-sam-
ple analysis was performed using the unpaired t test
assuming unequal variances. Presence of an aneurysm at
harvest was defined as an increase of 100% over the
preperfusion aortic diameter. The 2 (or Fisher exact test
when average cell size was less than 5) was used to test for
differences in incidence of AAA between groups. All
analyses were performed with JMP 5.1 statistical soft-
ware (SAS Institute Inc, Cary, NC, 1989-2003) for
Windows (Microsoft, Redmond, Wash). P  .05 wasmice were warmed to 38°C at each session. Six measure- considered significant.
